Related Experiment Video
Updated: Aug 6, 2026

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
Reintervention Before Bidirectional Cavopulmonary Shunt and Intermediate Outcomes in Children with Single Ventricle
Bhavikkumar D Langanecha1, Sajith Kesavan2, Steven M Schwartz3,4
1Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. bhavikkumar.langanecha@sickkids.ca.
Insights
Unplanned reinterventions after pulmonary artery banding (PAB) in single ventricle patients are common. Genetic syndromes are a risk factor for poor outcomes, necessitating further research into alternative palliative strategies for these patients.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Palliation
Background:
- Pulmonary artery banding (PAB) is a palliative procedure for single ventricle (SV) patients.
- Unplanned reinterventions are frequent before stage 2 palliation (S2P) in SV patients post-PAB.
- Risk factors for these reinterventions remain largely unknown.
Purpose of the Study:
- To identify risk factors associated with reinterventions after PAB in SV patients.
- To evaluate the impact of reinterventions on the success of subsequent stage 2 palliation.
- To explore outcomes in SV patients with genetic syndromes undergoing PAB.
Main Methods:
- Retrospective single-center study of 77 SV patients undergoing PAB (2000-2020).
- Cause-specific hazard regression and competing risk models analyzed reintervention and S2P rates.
- Multivariable models adjusted for clinical and statistical predictors.
Main Results:
- 13% of patients required reintervention within 18 months of PAB.
- Reinterventions included PAB adjustment (60%) and shunt conversion (40%).
- Genetic syndromes (p=0.025) were associated with poor outcomes, with only 25% reaching S2P.
Conclusions:
- PAB offers reasonable outcomes in SV patients but has a high reintervention rate.
- Genetic syndromes are a significant risk factor for adverse outcomes post-PAB.
- Alternative palliative strategies should be investigated for SV patients with genetic syndromes.
Abstract:
Unplanned reinterventions following pulmonary artery banding (PAB) in single ventricle patients are common before stage 2 palliation (S2P) but associated risk factors are unknown. We hypothesized that reintervention is more common when PAB is placed at younger age and with a looser band, reflected by lower PAB pressure gradient. Retrospective single center study of single ventricle patients undergoing PAB between Jan 2000 and Dec 2020. The association with reintervention and successful S2P was modeled using exploratory cause-specific hazard regression. A multivariable model was developed adjusting for clinical and statistically relevant predictors. The cumulative proportion of patients undergoing reintervention were summarized using a competing risk model. 77 patients underwent PAB at median (IQR) 47 (24-66) days and 3.73 (3.2-4.5) kg. Within18 months of PAB, 60 (78%) reached S2P, 9 (12%) died, 1 (1%) transplanted and 7 (9%) were alive without S2P. Within 18 months of PAB 10 (13%) patients underwent reintervention related to pulmonary blood flow modification: PAB adjustment (n = 6) and conversion to Damus-Kaye-Stansel/Blalock-Taussig-Thomas shunt (n = 4). 6/10 (60%) reached S2P following reintervention. A trend toward higher intervention in patients with a genetic syndrome (p-0.06) and weight < 3 kg (p-0.057) at time of PAB was noted. Only genetic syndrome was a risk factor associated with poor outcome (p-0.025). PAB has a reasonable outcome in SV patients with unobstructed systemic and pulmonary blood flow, but with a high reintervention rate. Only a quarter of patients with genetic syndromes reach S2P and further study is required to explore the benefits from an alternative palliative strategy.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

